Skip to main content
. 2022 Jul 29;9:931207. doi: 10.3389/fcvm.2022.931207

TABLE 1.

Demographic characteristics of the study population.

Overall (N = 155) Severe PPM (N = 10) Moderate PPM (N = 22) None (N = 123) P-value
Age 77.9 ± 7.7 77.5 ± 7.6 77.9 ± 7.5 79.2 ± 8.7 0.2
Male 89 (57.4%) 2 (20%) 8 (36%) 79 (64%) 0.002
BSA (m2) 1.8 ± 0.2 1.7 ± 0.07 1.8 ± 0.2 1.8 ± 0.2 0.4
BMI < 21 kg/m2 25 (16%) 1 (10%) 2 (9%) 22 (18%) 0.5
BMI > 30 kg/m2 19 (12%) 0 (0) 2 (9%) 17 (14%) 0.4
Hypertension 135 (87%) 10 (100%) 22 (100%) 103 (84%) 0.05
Dyslipidemia 104 (67%) 6 (60%) 20 (91%) 78 (65%) 0.04
Diabetes 19 (12%) 4 (40%) 6 (27%) 32 (26%) 0.7
Smoker 40 (26%) 2 (20%) 4 (21%) 34 (34%) 0.4
COPD 36 (23%) 3 (30%) 6 (27%) 27 (22%) 0.8
Severe renal failure 28 (18%) 3 (30%) 2 (9%) 23 (19%) 0.3
Dialysis 6 (4%) 1 (10%) 0 (0) 5 (4%) 0.4
Stroke 9 (6%) 1 (10%) 0 (0) 8 (7%) 0.4
Previous pacemaker 50 (32%) 3 (30%) 6 (27%) 41 (34%) 0.8
Previous cardiac surgery 30 (19%) 3 (30%) 4 (18%) 23 (19%) 0.3
HISTORY of MI 42 (27%) 2 (20%) 8 (36%) 32 (26%) 0.5
Previous PCI 65 (42%) 5 (50%) 6 (27%) 54 (45%) 0.3
NYHA III/IV 114 (74%) 7 (70%) 18 (82%) 89 (74%) 0.7
LV ejection Fraction (%) 49 ± 13.4 52.5 ± 10.3 52.6 ± 18.7 48.1 ± 13.1 0.3
Aortic valve area (cm2) 1.34 ± 0.7 0.75 ± 0.3 1.05 ± 0.5 1.44 ± 0.72 0.03
Euroscore I 20.3 ± 15.0 37.4 ± 17.3 18.4 ± 7.3 18.1 ± 13.0 0.01
Euroscore II 8.7 ± 7.5 15.5 ± 15.0 9.5 ± 1.8 8.2 ± 7.6 0.06
STS Score 6.3 ± 5.9 12.3 ± 14.9 4.7 ± 1.2 6.9 ± 5.7 0.03
Regurgitant degenerated 88 (57%) 3 (30%) 10 (46%) 75 (61%) 0.08
Stenotic degenerated 52 (34%) 3 (20%) 12 (55%) 37 (30%) 0.09
Mixed degenerated 15 (10%) 4 (40%) 0 11 (9%) 0.001

BSA, body surface area; BMI, body mass index; COPD, chronic obstructive pulmonary disease; LV, left ventricle; MI, myocardial infarction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; STS, Society of Thoracic Surgeons.